AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00389649 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: heart rate setting
Study NCT01706770 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: enfilcon A
Study NCT01706770 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: galyfilcon A
Study NCT02692352 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Goal Management Training
Description: Goal Management training, 8 sessions of 2 hours
Study NCT02692352 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Brain Health Workshop
Description: Brain Health Workshop training, 8 sessions of 2 hours
Study NCT03621020 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: T-TAS 01 PL Chip
Description: Flow chamber microchip system specific for measuring primary hemostatic ability
Study NCT03621020 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PFA-100 Col/Epi and Col/ADP
Description: System for measuring platelet dysfunction
Study NCT02109627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: 2 g/m2; intravenous; Days 2-7; Number of cycles: until progression or unacceptable toxicity develops.
Study NCT02374970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar stability exercises
Description: Four individualized learning sessions will be held during the same period of protocolized physiotherapy. Biofeedback training using the ultrasound machine will be performed in the first session, in order to show the specific contraction of the abdominal muscles with the stability exercises. The other three learning sessions will be performed without feedback, for the patient learn the exercises to make at home during the follow-up period.
Study NCT02374970 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocolized Physiotherapy
Description: Therapeutic exercises and thermotherapy during 12 daily sessions
Study NCT02374970 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protocolized Physiotherapy
Description: Therapeutic exercises and thermotherapy during 12 daily sessions
Study NCT01965743 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Contraception Information Packet
Description: The intervention will consist of brief education about IUC and development of interpersonal skills, including how to initiate conversations about reproductive health issues in social settings and debunking common IUC myths
Study NCT03113864 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily supplementation for 9 months
Study NCT03113864 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lutein
Description: Daily Supplementation for 9 months
Study NCT04009057 — intervention group
Intervention type: OTHER
Intervention: B/F/TAF
Description: B/F/TAF administered in accordance with the approved product monograph
Study NCT03886428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 100% portion size
Description: Entree portion size 100% of baseline
Study NCT03886428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 125% portion size
Description: Entree portion size 125% of baseline
Study NCT03886428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 150% portion size
Description: Entree portion size 150% of baseline
Study NCT03886428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 175% portion size
Description: Entree portion size 175% of baseline
Study NCT00868582 — intervention group
Intervention type: OTHER
Intervention: PET scanning in cancer
Description: Collection of institutional practice PET imaging data
Study NCT04407195 — intervention group
Intervention type: OTHER
Intervention: Exposure to the SARS-CoV-2
Description: This is an observational design. Participants are exposed to the Covid-19 pandemic.
Study NCT03445247 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Extracorporeal low-intensity shockwave
Description: Omnispec device to give a total of 1200 shockwaves, with low energy density at 0.1 mj/mm2 and a frequency of 120 shocks/min per kidney per treatment session, totally 12 times.
Study NCT03445247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extracorporeal low-intensity shockwave
Description: Omnispec device to give a total of 1200 shockwaves, with low energy density at 0.1 mj/mm2 and a frequency of 120 shocks/min per kidney per treatment session, totally 12 times.
Study NCT01389206 — intervention group
Intervention type: DRUG
Intervention: observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
Description: observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
Study NCT04084912 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone Sodium Phosphate
Description: intravenous injection of one ampoule dexamethasone Sodium phosphate 2 ml 8 mg
Study NCT04084912 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: intravenous injection of one ampoule saline
Study NCT04238468 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intradermal stromal vascular fraction injection
Description: After flank liposuction, lipoaspirate will be processed by enzymatic digestion, thus stromal vascular fraction will be isolated. Just after the wound is closed the stromal vascular fraction diluted in normal saline (5ml) will be injected intradermally on one site.
Study NCT02306603 — intervention group
Intervention type: PROCEDURE
Intervention: Endoscopic Mucosal Resection
Study NCT05060952 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Calprotectin Lateral Flow Test
Description: Semiquantitative point of care photometric assay for the calprotectin level in joint fluid aspirate
Study NCT04084028 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Cooking Classes
Description: 6 cooking classes will be held every week for 6 consecutive weeks. The lessons are patterned after Dr. Amy Trubek's cooking pedagogy and will be tailored for those cooking for themselves for the first time. Classes begin with a brief lecture on the day's topic. Students will work in teams of 2 in the foods lab to actively practice skills and cook a meal. Students receive recipes and information sheets that cover pantry supplies, grocery lists, knife skills and cooking equipment. All students attend a 2 hour kitchen intensive demonstration as an orientation.
Study NCT03068377 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Soft gel capsules containing a mixture of tomato extract, lutein, zeaxanthin as well as other phytonutrients and vitamins
Study NCT02488486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propofol
Study NCT02488486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remifentanil
Study NCT03068377 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: soft gel capsules without test material
Study NCT00941486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FST-100 Ophthalmic Suspension
Description: FST-100 (PVP-I 0.4% and dexamethasone 0.1%). A regimen of 2 drops 4 times a day while awake for 5 days.
Study NCT00941486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A regimen of 2 drops 4 times a day while awake for 5 days.
Study NCT01146119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Multimeric-001, 500 mcg
Description: Adjuvanted Multimeric-001 was administered twice with an interval of 19-23 days.
Study NCT01146119 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Adjuvanted PBS
Description: Adjuvanted PBS was administered twice with an interval of 19-23 days.
Study NCT01146119 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PBS and TIV 15%
Description: PBS (Phosphate Buffered Saline) was administered twice with an interval of 19-23 days and then 60 days later a 15% dose of commercial seasonal trivalent vaccine (season 2011) was administered.
Study NCT01146119 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PBS and TIV 50%
Description: PBS (Phosphate Buffered Saline) was administered twice with an interval of 19-23 days and then 60 days later a 50% dose of commercial seasonal trivalent vaccine (season 2011) was administered.
Study NCT03444181 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music lessons
Description: Also described as neurocognitive music therapy. Singing lessons will be provided once a week for a period of 12 months by a person with a qualification in music therapy, or by a person with a different relevant qualification (e.g. psychology and music teaching) under the supervision of a music therapist. Additionally, participants will have the opportunity to meet regularly (1-2 times per month) as a choir to sing the song they have learned together in a group.
Study NCT03444181 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Training intervention
Description: Cognitive training that is comparable in scope and extent to the music lessons, but not using music. Group training sessions will be provided once a week for a period of 12 months by a person with a qualification in physiotherapy or occupational therapy. Group activities may include group tours such as mountain hikes and the like (about 2 times per month) and will follow an established program for the elderly.
Study NCT01494883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction
Description: A weekly training of eight sessions lasting two and a half hours.
Study NCT04084028 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Cooking Classes
Description: 6 cooking classes will be held every week for 6 consecutive weeks. The lessons are patterned after Dr. Amy Trubek's cooking pedagogy and will be tailored for those cooking for themselves for the first time. Classes begin with a brief lecture on the day's topic. Students will work in teams of 2 in the foods lab to actively practice skills and cook a meal. Students receive recipes and information sheets that cover pantry supplies, grocery lists, knife skills and cooking equipment. All students attend a 2 hour kitchen intensive demonstration as an orientation.
Study NCT04084028 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meal Kits
Description: Students receive 6 weeks of home delivered meal kits. Meal kits include ingredients and detailed instructions for 3 meals, which each serve two people. Students may select meals from a list of 18 options that include vegan, vegetarian, and gluten free options.
Study NCT04084028 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Meal Kits
Description: Students receive 6 weeks of home delivered meal kits. Meal kits include ingredients and detailed instructions for 3 meals, which each serve two people. Students may select meals from a list of 18 options that include vegan, vegetarian, and gluten free options.
Study NCT04084028 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recipes
Description: Students are emailed a set of recipes once a week for 6 weeks. Recipes include options for breakfast, lunch, dinner, and snacks. Recipe sets include vegan, vegetarian, and gluten-free options. This intervention was cancelled by COVID-related disruptions and did not take place.
Study NCT04084028 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Recipes
Description: Students are emailed a set of recipes once a week for 6 weeks. Recipes include options for breakfast, lunch, dinner, and snacks. Recipe sets include vegan, vegetarian, and gluten-free options. This intervention was cancelled by COVID-related disruptions and did not take place.
Study NCT02234258 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral social skills
Study NCT02750618 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Burosumab
Description: solution for subcutaneous injection
Study NCT03173898 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PDL anesthesia versus local infiltration
Description: Every patient received the recommended volumes of 2% lidocaine with 1:100.000 epinephrine for PDL injection on the experimental side, and for local infiltration on the control side. A Visual Analogue Scale (VAS) was used to describe the pain felt during injection.
Study NCT03173898 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PDL anesthesia versus local infiltration
Description: Every patient received the recommended volumes of 2% lidocaine with 1:100.000 epinephrine for PDL injection on the experimental side, and for local infiltration on the control side. A Visual Analogue Scale (VAS) was used to describe the pain felt during injection.
Study NCT02234258 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Study NCT00311948 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telephone counseling + interactive website = more abstinence
Study NCT00311948 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral: interactive website
Study NCT00683722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prochymal™
Description: IV infusion of ex- vivo cultured adult human mesenchymal stem cells.
Study NCT00683722 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV infusion of excipient of Prochymal™.
Study NCT01415518 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Drug: Budesonide/formoterol (Symbicort Turbuhaler
Description: budesonide/formoterol (Symbicort Turbuhaler 160/4.5µg/inhalation, 2 inhalations twice daily)
Study NCT01415518 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Drug: ipratropium (AtroventTM)
Description: ipratropium (AtroventTM 20 µg/inhalation, 2 inhalations four times daily)
Study NCT01415518 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: theophylline SR
Description: theophylline SR (0.1g/tablet, 1 tablet p.o. twice daily)
Study NCT04527133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aprotinin
Description: Intravenous or inhalation
Study NCT02014116 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3009120 capsule
Description: Administered orally.
Study NCT02191774 — intervention group
Intervention type: PROCEDURE
Intervention: Medical abortion at home
Description: Medical abortion using Mifepristone at the clinic followed by Cytotec at home
Study NCT02461433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prevena
Description: Prevena Incision Management system
Study NCT02461433 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Dressing
Description: This involves standard of care dressing including but not limited to gauze.
Study NCT02499731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strong Hearts, Healthy Communities
Description: We will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized controlled intervention trial. We will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 8 intervention and 8 control communities. In addition, we will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' social network.
Study NCT02499731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strong Hearts, Healthy Women
Description: The Strong Hearts, Healthy Women (minimal intervention) will meet once per month for an hour each time for 6 months.~Participants will learn and discuss techniques and strategies to improve personal health.
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (fasting)
Description: Participants will receive placebo once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (fasting)
Description: Participants will receive placebo once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (feeding)
Description: Participants will receive placebo once after meal condition
Study NCT01970033 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: * Run in period ：oral tablets of Placebo twice daily for 2 weeks~* Phase A : oral tablets of Placebo twice daily for 24 weeks~* Phase B : SP2086 50 mg b.i.d or SP2086 100 mg q.d. for 28 weeks
Study NCT01970033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SP2086 50 mg b.i.d.
Description: * Run-in period: placebo twice daily for 2 weeks~* Phase A:SP2086 50 mg b.i.d for 24 weeks~* Phase B:SP2086 50 mg b.i.d for 28 weeks
Study NCT01970033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SP2086 100 mg q.d.
Description: * Run-in period:placebo twice daily for 2 weeks~* Phase A: SP2086 100 mg q.d. for 24 weeks~* Phase B: SP2086 100 mg q.d. for 28 weeks
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (feeding)
Description: Participants will receive placebo once after meal condition
Study NCT05719974 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rehabilitation protocol
Description: Current conventional protocols were based mainly on biological tissue healing time frames. These protocols emphasize pain reduction, full passive knee extension, quadriceps strength training, immediate motion, immediate par¬tial weight bearing (only if there is a correct gait pattern without any complications), and functional exercises The criterion-based rehabilitation protocol is relatively new. It was developed and recommended in 2016 by the Royal Dutch Society for Physical Therapy (KNGF), aiming to assure a more patient-tailored rehabilitation and to maximize the speed of a patient's progress. It's a three phases protocol with a criterion-based progression.
Study NCT05719974 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rehabilitation protocol
Description: Current conventional protocols were based mainly on biological tissue healing time frames. These protocols emphasize pain reduction, full passive knee extension, quadriceps strength training, immediate motion, immediate par¬tial weight bearing (only if there is a correct gait pattern without any complications), and functional exercises The criterion-based rehabilitation protocol is relatively new. It was developed and recommended in 2016 by the Royal Dutch Society for Physical Therapy (KNGF), aiming to assure a more patient-tailored rehabilitation and to maximize the speed of a patient's progress. It's a three phases protocol with a criterion-based progression.
Study NCT02356380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilization Type
Description: Group One: Mobilization Group: this group will receive grade 1,2,3,or 4 mobilization in prone based on the PT's clinical judgement. The treatment parameters will be recorded.~Group Two: Grade 3-4 mobilization group: this group will receive a grade 3-4 mobilization, for 30 seconds form the first through sixth thoracic vertebrae.
Study NCT02522533 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Therapy
Description: 6 weeks of an exercise program.
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 1 mg of TS-142
Description: Participants will receive 1 mg of TS-142 once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1 mg of TS-142
Description: Participants will receive 1 mg of TS-142 once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3 mg of TS-142
Description: Participants will receive 3 mg of TS-142 once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3 mg of TS-142
Description: Participants will receive 3 mg of TS-142 once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 10 mg of TS-142 (fasting)
Description: Participants will receive 10 mg of TS-142 once in fasting condition
Study NCT03111927 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Infant Formula: enriched level of myelin-relevant nutrients
Description: Feeding with the assigned infant formula begun as soon as the child was enrolled in the study (from 2 weeks up to 5 weeks of life) and lasted up to 12 months of age (+/- 2 weeks).~The volume of feed required by the child per day depended upon age, weight, and appetite. The product was given daily ad libitum to the child from enrollment up to 12 months.
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg of TS-142 (fasting)
Description: Participants will receive 10 mg of TS-142 once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 10 mg of TS-142 (feeding)
Description: Participants will receive 10 mg of TS-142 once after meal condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg of TS-142 (feeding)
Description: Participants will receive 10 mg of TS-142 once after meal condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 30 mg of TS-142
Description: Participants will receive 30 mg of TS-142 once in fasting condition
Study NCT04169893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 30 mg of TS-142
Description: Participants will receive 30 mg of TS-142 once in fasting condition